Sponsor content
184 result(s) found, displaying 81 to 90
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29-07-2023
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROSUVASTATIN ME 10 rosuvastatin (as calcium) 10 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROSUVASTATIN ME 20 rosuvastatin (as calcium) 20 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROSUVASTATIN ME 40 rosuvastatin (as calcium) 40 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROSUVASTATIN ME 20 rosuvastatin (as calcium) 20 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROSUVASTATIN MRX 20 rosuvastatin (as calcium) 20 mg tablet bottle.